Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Abelcet now approved in 18 countries

Jan. 5, 1998

Antifungal agents prepared at Pola

Jan. 5, 1998

Anti-MRSA agents prepared at Bristol-Myers Squibb

Jan. 2, 1998

New antifungals from Lilly

Jan. 2, 1998

Abbott synthesizes a novel series of cyclic antifungal agents

Jan. 2, 1998

Raxar --new once-daily fluoroquinolone-- now available in U.S.

Dec. 31, 1997

New antifungals disclosed by Schering-Plough

Dec. 31, 1997

Lilly develops compounds for the common cold; selects development candidate

Dec. 30, 1997

Aronex/Ferrer seek approval of Nyotran in Spain

Dec. 29, 1997

Lidak submits NDA for Lidakol

Dec. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...